175 related articles for article (PubMed ID: 33901715)
1. The Clinical Characteristics of Noninfectious Occlusive Retinal Vasculitis.
Huvard MJ; Pecen PE; Palestine AG
Ophthalmol Retina; 2022 Jan; 6(1):43-48. PubMed ID: 33901715
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions.
Agarwal A; Karkhur S; Aggarwal K; Invernizzi A; Singh R; Dogra MR; Gupta V; Gupta A; Do DV; Nguyen QD
Clin Exp Ophthalmol; 2018 Jan; 46(1):62-74. PubMed ID: 28557287
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis.
Sharief L; Lightman S; Blum-Hareuveni T; Bar A; Tomkins-Netzer O
Am J Ophthalmol; 2017 May; 177():206-212. PubMed ID: 28263735
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography.
Karampelas M; Sim DA; Chu C; Carreno E; Keane PA; Zarranz-Ventura J; Westcott M; Lee RW; Pavesio CE
Am J Ophthalmol; 2015 Jun; 159(6):1161-1168.e1. PubMed ID: 25709064
[TBL] [Abstract][Full Text] [Related]
5. Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
Baumal CR; Spaide RF; Vajzovic L; Freund KB; Walter SD; John V; Rich R; Chaudhry N; Lakhanpal RR; Oellers PR; Leveque TK; Rutledge BK; Chittum M; Bacci T; Enriquez AB; Sund NJ; Subong ENP; Albini TA
Ophthalmology; 2020 Oct; 127(10):1345-1359. PubMed ID: 32344075
[TBL] [Abstract][Full Text] [Related]
6. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Monés J; Srivastava SK; Jaffe GJ; Tadayoni R; Albini TA; Kaiser PK; Holz FG; Korobelnik JF; Kim IK; Pruente C; Murray TG; Heier JS
Ophthalmology; 2021 Jul; 128(7):1050-1059. PubMed ID: 33207259
[TBL] [Abstract][Full Text] [Related]
7. RETINAL VASCULITIS, A COMMON MANIFESTATION OF IDIOPATHIC PEDIATRIC UVEITIS?
Yang P; Zhong Z; Su G; Ye X; Tan S; Li F; Du L; Zhou C; Cao Q; Wang Y; Kijlstra A
Retina; 2021 Mar; 41(3):610-619. PubMed ID: 32658162
[TBL] [Abstract][Full Text] [Related]
8. A Novel Method to Detect and Monitor Retinal Vasculitis Using Swept-Source OCT Angiography.
Noori J; Shi Y; Yang J; Gregori G; Albini TA; Rosenfeld PJ; Davis JL
Ophthalmol Retina; 2021 Dec; 5(12):1226-1234. PubMed ID: 33610835
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Wide Field Imaging Characteristics of Primary Retinal Vasculitis: Risk Factors for Retinal Neovascularization.
Sheemar A; Temkar S; Takkar B; Sood R; Sinha S; Chawla R; Vohra R; Venkatesh P
Ocul Immunol Inflamm; 2019; 27(3):383-388. PubMed ID: 30207804
[No Abstract] [Full Text] [Related]
10. The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis.
Abraham A; Saboo US; Ducca BL; Lawand AT; Ronconi C; Cao JH
Ophthalmol Retina; 2020 Feb; 4(2):198-203. PubMed ID: 31708487
[TBL] [Abstract][Full Text] [Related]
11. Frosted Branch Angiitis Secondary to Granulomatosis with Polyangiitis.
Kim DY; Jeong J; Kim JY
Korean J Ophthalmol; 2019 Oct; 33(5):485-486. PubMed ID: 31612663
[No Abstract] [Full Text] [Related]
12. Role of ultra-widefield fluorescein angiography in the management of uveitis.
Hong BK; Nazari Khanamiri H; Rao NA
Can J Ophthalmol; 2013 Dec; 48(6):489-93. PubMed ID: 24314409
[TBL] [Abstract][Full Text] [Related]
13. Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report.
Lee EK; Oh BL; Yoon CK; Park UC
BMC Ophthalmol; 2022 Jun; 22(1):244. PubMed ID: 35659269
[TBL] [Abstract][Full Text] [Related]
14. Further observations on a bilateral IRVAN syndrome case.
Rodríguez Á; Carpio-Rosso W; Rodríguez FJ
Int Ophthalmol; 2019 May; 39(5):1179-1186. PubMed ID: 29948501
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Incidence Rates of Ocular Complications in Patients With Retinal Vasculitis.
Mir TA; Reddy AK; Burkholder BM; Walsh J; Shifera AS; Khan IR; Thorne JE
Am J Ophthalmol; 2017 Jul; 179():171-178. PubMed ID: 28501390
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Therapeutic Challenges.
Khundkar T; Johnson B; Mehta S
Retina; 2020 Feb; 40(2):387-390. PubMed ID: 31972810
[No Abstract] [Full Text] [Related]
17. Retinal Vasculitis in Anti-Synthetase Syndrome.
Donovan CP; Pecen PE; Baynes K; Ehlers JP; Srivastava SK
Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):874-9. PubMed ID: 27631486
[TBL] [Abstract][Full Text] [Related]
18. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Course in Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis.
Zahid S; Jiang Y; Dunn E; Mieler WF; Chau FY
Ophthalmol Retina; 2019 Apr; 3(4):380-381. PubMed ID: 31014692
[No Abstract] [Full Text] [Related]
20. Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
Baumal CR; Bodaghi B; Singer M; Tanzer DJ; Seres A; Joshi MR; Feltgen N; Gale R
Ophthalmol Retina; 2021 Jun; 5(6):519-527. PubMed ID: 33007521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
